Development and Evaluation of Nanocarriers for Treatment of Lung Cancer

A thorough understanding of the application of nanotechnology in the treatment of lung cancer may be found in Prachi Mehendale's article, "Development and Assessment of Nanocarriers for Treatment of Lung Cancer." Due to the toxicity and low absorption of anticancer medications, lung cancer is one of the main causes of cancer-related fatalities globally. The author of this book examines the creation and assessment of nanocarriers as a potentially effective method for enhancing drug delivery and enhancing the therapeutic efficacy of lung cancer treatment.

The design and production of numerous forms of nanocarriers, including liposomes, solid lipid nanoparticles, and polymeric nanoparticles, are covered in the book along with other facets of nanocarrier-based drug delivery. It also examines the effectiveness of these nanocarriers for drug delivery and their potential for treating lung cancer. The physicochemical characteristics, biocompatibility, and safety issues of these nanocarriers have all been described in great length by the author.

For researchers and students interested in nanotechnology-based drug delivery methods for cancer treatment, the book is a great resource. It discusses the current state of the field's research as well as how nanocarrier technology has the ability to completely change the way cancer therapy is practised. A wide spectrum of readers can easily understand the content because it is presented in a clear, brief, and simple manner. Overall, the book "Development and Assessment of Nanocarriers for Treatment of Lung Cancer" is insightful and educational, and it will be useful to researchers, doctors, and students who are interested in cancer therapy and nanomedicine.